Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

75647 Press Releases
DateTitleCompany
31 Oct 12 Seattle Genetics Announces ADCETRIS® Receives European Commission Conditional Marketing Authorization Seattle Genetics Inc.,
Published by
Business Wire
31 Oct 12 ARIAD to Webcast Conference Call on Third Quarter 2012 Financial Results ARIAD Pharmaceuticals Inc.,
Published by
Business Wire
31 Oct 12 Spectrum Pharmaceuticals Announces Third Quarter 2012 Financial Results Teleconference and Webcast Spectrum Pharmaceuticals,
Published by
Business Wire
31 Oct 12 DaVita to Present Twelve Posters and One Oral Presentation at American Society of Nephrology Kidney Week DaVita Inc.,
Published by
Business Wire
31 Oct 12 Dr. Alex Aimetti of InVivo Therapeutics to Speak at Working 2 Walk Spinal Cord Injury Symposium InVivo Therapeutics Holdings Corp.,
Published by
Business Wire
31 Oct 12 Medidata Solutions Reports Third Quarter 2012 Results Medidata Solutions,
Published by
Business Wire
31 Oct 12 EnVivo Pharmaceuticals Presents Additional EVP-6124 Phase 2b Clinical Trial Results at the Clinical Trials on Alzheimer’s Disease (CTAD) Meeting EnVivo Pharmaceuticals,
Published by
Business Wire
31 Oct 12 Launch of Medicor Global Medicor Global
31 Oct 12 Takeda and Millennium Announce European Conditional Marketing Authorisation for ADCETRIS® (Brentuximab Vedotin) Millennium: The Takeda Oncology Company,
Published by
Business Wire
31 Oct 12 Millennium and Takeda Announce European Conditional Marketing Authorization for ADCETRIS® (Brentuximab Vedotin) Millennium: The Takeda Oncology Company,
Published by
Business Wire
31 Oct 12 Change in number of shares and votes in Aerocrine Aerocrine,
Published by
Business Wire
31 Oct 12 Inspiration Biopharmaceuticals Files for Chapter 11 Protection in Order to Pursue a Broad Strategic Transaction Inspiration Biopharmaceuticals Inc.,
Published by
Business Wire
31 Oct 12 Ipsen’s hemophilia partner, Inspiration Biopharmaceuticals, seeks Chapter 11 protection Ipsen,
Published by
Business Wire
31 Oct 12 Anthem Blue Cross and Blue Shield in Maine Adjusts Health and Pharmacy Guidelines for Members Affected by Hurricane Sandy Anthem Blue Cross and Blue Shield in Maine,
Published by
Business Wire
31 Oct 12 Anthem Blue Cross and Blue Shield in New Hampshire Adjusts Health and Pharmacy Guidelines for Members Affected by Hurricane Sandy Anthem Blue Cross and Blue Shield in New Hampshire,
Published by
Business Wire
31 Oct 12 Anthem Blue Cross and Blue Shield in Connecticut Adjusts Health and Pharmacy Guidelines for Members Affected by Hurricane Sandy Anthem Blue Cross and Blue Shield in Connecticut,
Published by
Business Wire
31 Oct 12 Anthem Blue Cross and Blue Shield in Virginia Adjusts Health and Pharmacy Guidelines for Members Affected by Hurricane Sandy Anthem Blue Cross and Blue Shield in Virginia,
Published by
Business Wire
31 Oct 12 BioCryst Provides Update Regarding BCX5191 Development Plan Following Discussion With FDA BioCryst Pharmaceuticals Inc.,
Published by
Business Wire
31 Oct 12 Anika Therapeutics Reports Third-Quarter Financial Results Anika Therapeutics Inc.,
Published by
Business Wire
31 Oct 12 Affymetrix Reschedules the Issuance of Third Quarter 2012 Operating Results and Conference Call to Monday November 5th, 2012 Due to Severe Weather Conditions Associated with Hurricane Sandy Affymetrix Inc.,
Published by
Business Wire
31 Oct 12 Exactech Q3 Revenue Up 8% to $51.3M, Net Income Up 95% to $2.6M, EPS $0.19; YTD Revenue Up 8% to $165.1M, Net Income $8.9M, EPS $0.67 Exactech Inc.,
Published by
Business Wire
31 Oct 12 Charles River Laboratories Announces Third-Quarter 2012 Results from Continuing Operations Charles River Laboratories International Inc.,
Published by
Business Wire
31 Oct 12 Charles River Laboratories to Expand Research Models Business in China Charles River Laboratories International Inc.,
Published by
Business Wire
31 Oct 12 Cardiovascular Systems Reports Fiscal 2013 First-Quarter Financial Results Cardiovascular Systems Inc.,
Published by
Business Wire
31 Oct 12 Thermo Fisher Scientific to Present at Baird’s 2012 Industrial Conference on November 6, 2012 Thermo Fisher Scientific Inc.,
Published by
Business Wire
31 Oct 12 Research and Markets: Exanthema - Pipeline Review, H2 2012 Research and Markets,
Published by
Business Wire
31 Oct 12 AB Science reports phase 3 study results of masitinib in combination with Gemzar® for treatment of pancreatic cancer. AB Science SA,
Published by
Business Wire
31 Oct 12 Molex Adds Innovative Products To its MediSpec™ Portfolio Demonstrating Commitment to Global Medical Electronics Molex Incorporated,
Published by
Business Wire
31 Oct 12 Research and Markets: Macular Edema - Pipeline Review, H2 2012 Research and Markets,
Published by
Business Wire
31 Oct 12 iCAD Reports Third Quarter Financial Results iCAD Inc.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.